2016 pharmaceutical industry policy densely introduced，Involved in production、R & D to market sales、Clinical use、Medical insurance reimbursement in various industrial chains。With this change of industrial policy，Various levels of human resources in the local pharmaceutical industry also changes，From the statistical data Stake Sports Bettingof My stake betting appYianhan Weit，The changes worthy of attention are mainly in the following aspects:

 

  The number of people increased in full slowly

 

  The growth rate of employees in the pharmaceutical industry in 2017 further decreased，The growth rate of employees in 2016 in local pharmaceutical companies is 10.8%，It is expected to drop to 8.7%in 2017; the number of foreign pharmaceutical companies increases the slowest，Almost cut，From 8.6%in 2015，It is expected that it will drop to 4.9%by 2017。

 

  In all departments of pharmaceutical companies，Sales、R & D、The department with the largest number of people is the most increased.，The expected growth rate of 2016 is 19.3%、17.2%、16%。

 

  Foreign -funded pharmaceutical companies are high in departure rate

 

  2016 pharmaceutical industry's departure rate is generally 20.45%，Among them, foreign pharmaceutical companies are significantly higher than local pharmaceutical companies。

 

  The departure rate of local pharmaceutical companies is expected to reach a high point in four years，17.9%，2015 This number is 16.6%。Another thing worthy of attention is，2016's active departure rate will rise significantly，It is expected to reach 15.1%。

 

  but but，Compared with local pharmaceutical companies，The departure rate of foreign pharmaceutical companies is higher，This to some extent，illustrates the survival status of foreign pharmaceutical companies in China。

 

  Stake Sports BettingData My stake betting appdisplay，Foreign -funded pharmaceutical companies' departure rate in 2016 is 23%，Among them, the active departure rate is 15.9%，Passive resignation rate is 7.1%。Actually，For the past four years，The departure rate of foreign pharmaceutical companies in China has always been at a high level，2013 ~ 2016，Resignation rates are 25.3%、23.3%、More than 20%。More than 20%。

 

  Specific reasons for departure，Interviews with employees with resigned，Whether it is local or foreign capital，It is mainly concentrated in 8 aspects。The top three are limited in career development opportunities、Salary lacks external competitiveness and work and life cannot be balanced。In addition，Lack of sufficient recognition，Lack of internal fairness in salary、Welfare projects lack competitiveness、The management team is not satisfied and the work content is not satisfied，It is also the cause of employees' resignation。

 

  2016 salary increased by 7.7%

 

  According to Han Weite's statistical data，The average salary of 2016 in the pharmaceutical industry increased by 7.7%。Where，Salary growth of local pharmaceutical companies is significantly higher than foreign pharmaceutical companies，1.4%higher。

 

  stake sports betting app2016 Chinese local pharmaceutical companies' overall salary ratio (excluding promotion) stake betting appan average of 8.4%，It is expected to be from 2017，This number is slightly reduced，is 8.3%。

 

  Starting in 2012，The salary growth rate of foreign pharmaceutical companies began to decrease year by year，9.7%in 2012，dropped to 7.0%in 2016。

 

  Must be acknowledged，Industrial policy environment under the normal normal，Higher requirements for human resources work in the pharmaceutical industry，Yianhan Weit believes，The human resources work of the current leading pharmaceutical companies should focus on the following three aspects:

 

  First，Improve the effectiveness of human capital，& ldquo; Strict control of people，Rebelling Human Effects & RDQUO; Has become the unanimous choice for many leading companies。

 

  Second，Tilt the focus of motivated to high -performance employees，Take a variety of ways to retain the core personnel。

 

  Third，Development of the leadership of middle executives，Cultivate leading talents to support the diversified development of enterprises。